Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04873037 · ClinicalTrials.gov registry record · NA

BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder

A NA study of Overactive Bladder and Overactive Bladder Syndrome, sponsored by Corewell Health East.

Recruiting
Registry status
NA
Development phase
166
Enrollment target
1
Study location

NCT04873037 is a NA study of Overactive Bladder and Overactive Bladder Syndrome that is actively recruiting participants, run by Corewell Health East. The registered enrollment target is 166 participants, below the 208-participant average among 45 other Overactive Bladder trials with a reported enrollment target (20% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04873037, a NA study of Overactive Bladder and Overactive Bladder Syndrome, is actively recruiting participants, sponsored by Corewell Health East.

RECRUITING
Registry status
NA
Development phase
166 participants
Enrollment target
1
Study location

Study Summary

The purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the treatment of overactive bladder (OAB). Currently there are no other studies utilizing the Emsella Chair for the treatment of OAB. Eligible subjects will receive 2 treatments per week for a total of 4 weeks.

Conditions Studied

Overactive Bladder Overactive Bladder Syndrome Urinary Frequency Urinary Urgency

Interventions

  • DEVICE BTL Emsella Chair
  • DEVICE Sham BTL Emsella Chair

Study Locations (1)

Michigan

  • Corewell Health William Beaumont University Hospital - Royal Oak

Trial Details

FieldValue
Enrollment Target 166 participants
Start Date 2021-11-22
Est. Completion 2028-12
Phase NA

Sponsor

Corewell Health East

106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04873037

The ClinicalTrials.gov registry entry for NCT04873037 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 208-participant average among 45 other Overactive Bladder trials with a reported enrollment target (20% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Overactive Bladder appearing as the primary indexed condition, and to 2 interventions - of which BTL Emsella Chair is the first listed.

NCT04873037 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04873037 about?

NCT04873037 is a clinical study titled "BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder". The purpose of this clinical trial is to compare the Emsella Chair therapy to Sham and to determine whether electromagnetic technology is effective in the treatment of overactive bladder (OAB). Currently there are no other studies utilizing the Emsella Chair for the treatment of OAB. Eligible subjec...

What is the current status of trial NCT04873037?

This trial is currently recruiting. It is a NA study. The enrollment target is 166 participants. The study started on 2021-11-22. Estimated completion is 2028-12.

What conditions does trial NCT04873037 study?

This clinical trial studies the following conditions: Overactive Bladder, Overactive Bladder Syndrome, Urinary Frequency, Urinary Urgency.

What interventions are being tested in trial NCT04873037?

The interventions under investigation include: BTL Emsella Chair (DEVICE), Sham BTL Emsella Chair (DEVICE).

Who is sponsoring clinical trial NCT04873037?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04873037 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Overactive Bladder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Overactive Bladder

All registered trials for this condition

Overactive Bladder Syndrome

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.